Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001221590-26-000005

Director bought 1,000 shares at $11.70 ($11,700)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BIENAIME JEAN JACQUES · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-15 Purchase : show line 1 in the form 10b5-1 +1,000 $11.70 $11,700 8,450 D
Open-market purchases · 1,000 sh · avg $11.70 · $11,700
Loading xslF345X06/form4-04172026_040401.xml…